429669-41-0

Upstream product

• 429669-36-3 [(1S)-1-(t-butyldiphenylsilyloxymethyl)propyl]carbamic acid benzyl ester 
• 5856-62-2 (S)-2-aminobutan-1-ol 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 1021869-75-9 C₂₂H₃₀ClNO₂Si 

Relevant academic research and scientific papers

Design, synthesis, and evaluation of novel ethambutol analogues

Ethambutol is one of the front-line agents recommended by the World Health Organization for the treatment of tuberculosis. In an effort to develop more potent therapies to treat tuberculosis, novel unsymmetrical ethambutol analogues were successfully synt

1-Methylcarbapenem derivatives

1-Methylcarbapenem compounds having antibacterial activity, pharmacologically acceptable esters or salts thereof and pharmaceutical compositions (particularly antibacterial agents) containing them as an active ingredient are described. In addition, the invention includes the use of these compounds, ester derivatives or salts for the manufacture of pharmaceutical compositions, or a method for the prevention or treatment of diseases (particularly bacterial infections) by administering a pharmacologically effective amount of the compounds, ester derivatives or salts to warm-blooded animals (particularly human beings).